Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Kaleido Biosciences, Inc. (KLDO)

0.0050
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2021
12/31/2020
Total Revenue
1,104
1,104
975
Operating Expense
88,771
88,771
79,849
Operating Income
-87,667
-87,667
-78,874
Net Non Operating Interest Income Expense
-2,766
-2,766
-2,553
Other Income Expense
145
145
-193
Pretax Income
-90,288
-90,288
-81,620
Net Income Common Stockholders
-90,288
-90,288
-81,620
Diluted NI Available to Com Stockholders
-90,288
-90,288
-81,620
Basic EPS
-2.16
--
-2.44
Diluted EPS
-2.16
--
-2.44
Basic Average Shares
41,859.9930
--
33,450.2130
Diluted Average Shares
41,859.9930
--
33,450.2130
Total Operating Income as Reported
-87,667
-87,667
-78,874
Total Expenses
88,771
88,771
79,849
Net Income from Continuing & Discontinued Operation
-90,288
-90,288
-81,620
Normalized Income
-90,288
-90,288
-81,620
Interest Income
72
72
249
Interest Expense
2,838
2,838
2,802
Net Interest Income
-2,766
-2,766
-2,553
EBIT
-87,450
-87,450
-78,818
EBITDA
-85,092
-85,092
-76,995
Reconciled Depreciation
2,358
2,358
1,823
Net Income from Continuing Operation Net Minority Interest
-90,288
-90,288
-81,620
Normalized EBITDA
-85,092
-85,092
-76,995
12/31/2020 - 2/28/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers